Scarica l'app Stockscreener
7.29
1.22%
-0.09
Dopo l'orario di chiusura:
7.35
0.06
+0.82%
Pavmed Inc Borsa (PAVM) Ultime notizie
PAVmed Announces Reverse Stock Split - citybiz
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - MarketScreener
PAVMED announces 1-for-30 reverse stock split - MSN
PAVmed trading halted, news pending - MSN
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
PAVmed stock drops after announcing 1-for-30 reverse split By Investing.com - Investing.com Canada
PAVmed (PAVM) Announces 1-for-30 Reverse Stock Split - GuruFocus
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
PAVmed to implement 1-for-30 reverse stock split in January - Investing.com Nigeria
PAVmed stock drops after announcing 1-for-30 reverse split - Investing.com India
PAVmed to implement 1-for-30 reverse stock split in January By Investing.com - Investing.com South Africa
PAVmed Announces Reverse Stock Split to Maintain Nasdaq Listing - TipRanks
PAVmed announces reverse stock split - marketscreener.com
Why this medical tech company is shrinking its stock 1-for-30 next week - Stock Titan
PAVmed announces reverse stock split to maintain Nasdaq listing - MSN
PAVmed Inc. (NASDAQ:PAVM) Sees Large Drop in Short Interest - Defense World
Here's Why Lucid Diagnostics (LUCD) Declined in Q3 - Finviz
Is PAVmed Inc. stock a buy on dips2025 Technical Overview & Free Fast Gain Swing Trade Alerts - Улправда
Nasdaq Moves: Will PAVmed Inc. stock gain from strong economyEarnings Trend Report & Reliable Price Breakout Alerts - Улправда
Will PAVmed Inc. stock gain from strong economy2025 Price Momentum & Free Low Drawdown Momentum Trade Ideas - Улправда
PAVM FinancialsIncome Statement - Quiver Quantitative
Ascendiant Capital Maintains PAVmed (PAVM) Buy Recommendation - Nasdaq
Ascendiant Capital Lowers Price Target for PAVmed (PAVM) to $17. - GuruFocus
PAVmed stock price target lowered to $17 from $20 at Ascendiant Capital By Investing.com - Investing.com South Africa
PAVmed stock price target lowered to $17 from $20 at Ascendiant Capital - Investing.com
Lucid Diagnostics reports real-world data on esophageal test device By Investing.com - Investing.com Australia
Lucid Diagnostics reports real-world data on esophageal test device - Investing.com
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection - PR Newswire
PAVmed approves reverse stock split amendment - MSN
PAVmed Approves Reverse Stock Split Amendment - The Globe and Mail
Lucid Diagnostics Announces $15.3 Million Registered Direct Offe - GuruFocus
Can PAVmed Inc. stock rebound after recent weaknessMarket Growth Report & Daily Market Momentum Tracking - Newser
Is PAVmed Inc. stock cheap compared to fundamentals2025 Short Interest & Capital Efficiency Focused Ideas - Newser
PAVmed (PAVM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
What drives PAVmed Inc stock priceInflation Impact on Stocks & Control Your Emotions With Discipline Tools - earlytimes.in
Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest shareholders are individual investors with 38% ownership, public companies own 30% - Yahoo Finance Singapore
Risk Check: Will PAVmed Inc. stock gain from strong economyRecession Risk & Advanced Swing Trade Entry Plans - BỘ NỘI VỤ
Why Being Public Gave PavMed a Competitive Edge - Medical Device and Diagnostic industry
What analysts say about PAVmed Inc stockPrice Channel Trading & Small Investment Capital Tips - earlytimes.in
Pavmed Inc. Reports Q3 2025 Earnings and Strategic Focus - MSN
Will PAVmed Inc. stock benefit from upcoming earnings reports2025 Retail Activity & Low Drawdown Investment Strategies - newser.com
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree - PR Newswire
Will PAVmed Inc. stock deliver strong dividend growthStop Loss & Weekly Top Stock Performers List - newser.com
GenomeWeb Names Lucid Diagnostics (Nasdaq: LUCD) 2025 Best Places to Work Honoree - Stock Titan
Is PAVmed Inc. stock ready for breakoutPortfolio Gains Report & Community Driven Trade Alerts - newser.com
Is PAVmed Inc. stock cheap at current valuationJuly 2025 Gainers & Consistent Growth Equity Picks - newser.com
Combining machine learning predictions for PAVmed Inc.July 2025 Analyst Calls & Daily Technical Stock Forecast Reports - newser.com
2.10%
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):